The London Technology and Life Sciences team advised Montage Ventures on its lead investment in a $6.5 million seed round for CardiaTec.
Founded in 2021, CardiaTec is leveraging artificial intelligence and multi-omics data to revolutionize drug target discovery for cardiovascular diseases.
Montage Ventures is an early-stage fund focused on the Pre-Seed, Seed, and Series A stages, backing technical founders bringing innovations to verticals such as fintech, commerce and healthcare.
The Goodwin deal was led by Sophie McGrath and Ben Taylor.
For more details on the investment, please see the press release.